Health
Botanix collab with UQ confirms antimicrobial potential of CBD – Stockhead
Botanix Pharmaceuticals shares are on the rise after research showed that a synthetic cannabidiol formulation can kill so-called “superbugs”.
Link copied toclipboard
BotanixPharmaceuticals (ASX:BOT) shares are on the rise this morning after research from the University of Queensland showed that a synthetic cannabidiol formulation can kill so-called “superbugs”, or gram-negative bacteria.
CBD can destroy the bacteria responsible for gonorrhoea, meningitis and legionnaire’s disease, according to the Botanix-backed article published today in the peer-reviewed journal Communications Biology.
“Our results demonstrate that cannabidiol has excellent…
-
Business23 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News18 hours agoTwo trapped and fighting for life after major three-vehicle crash in Brisbane
-
Business19 hours agoUp 105% in a year, are Pro Medicus shares still a good buy today?
-
Noosa News14 hours agoQueensland man sentenced to four years imprisonment after string of terror offences